Medicago and GSK to begin final Covid-19 vaccine trials
Canada's Medicago and British pharmaceutical giant GlaxoSmithKline (GSK) announced Thursday the launch of phase 2 and 3 clinical trials on a COVID-19 vaccine, one of a series of candidates being developed worldwide.
Nov 12, 2020
0
4